Related Experiment Videos
Use of racecadotril as outpatient treatment for acute gastroenteritis: a prospective, randomized, parallel study
Mar Santos1, Rafael Marañón, Concepión Miguez
1Department of Pediatrics, Hospital General Universitario Gregorio Marañón, Madrid, Spain. marimarsantos5@hotmail.com
Insights
Racecadotril did not improve diarrhea symptoms in children treated with oral rehydration alone. This study found no significant differences in bowel movements or gastroenteritis duration between groups. Further research may be needed.
Area of Science:
- Pediatric Gastroenterology
- Clinical Pharmacology
Background:
- Acute gastroenteritis is a common pediatric illness.
- Oral rehydration therapy (ORT) is the standard treatment.
- Racecadotril is a potential adjunct therapy to reduce fluid secretion.
Purpose of the Study:
- To evaluate the efficacy of racecadotril combined with ORT versus ORT alone in pediatric gastroenteritis.
- To compare symptom resolution and treatment duration in young children.
Main Methods:
- A prospective, randomized, open-label study.
- 189 children (3-36 months) with acute gastroenteritis were enrolled.
- Participants received either ORT alone or ORT plus racecadotril.
Main Results:
- No significant difference in the number of bowel movements within 48 hours between groups (4.1 vs 3.8).
- Average duration of gastroenteritis was similar (4.7 days vs 4.0 days; P = .15).
- Adverse event incidence was comparable between the oral rehydration (OR) and oral rehydration plus racecadotril (OR + R) groups.
Conclusions:
- Racecadotril did not demonstrate improved efficacy for diarrhea symptoms in this pediatric cohort.
- Standard oral rehydration therapy remains the primary treatment approach.
- The addition of racecadotril did not offer significant clinical benefits over ORT alone.
Objective:
To compare the efficacy of therapy with racecadotril plus oral rehydration versus oral rehydration alone in children with gastroenteritis in an outpatient setting care.
Study Design:
Prospective, randomized, open and parallel study performed in a Pediatric Emergency Service of a tertiary care hospital. The study included 189 patients, ages 3 to 36 months, with acute gastroenteritis: 94 were administered an oral rehydration solution (OR), 94 received oral rehydration solution plus racecadotril (OR + R). The principal variable studied was the number of bowel movements in 48 hours after initiating treatment.
Results:
The groups were comparable clinically and epidemiologically at enrollment. No significant differences were found in the number of bowel movements between the 2 groups 48 hours after initiating treatment (4.1 +/- 2.7 bowel movements in the OR group vs 3.8 +/- 2.4 bowel movements in the OR + R group). No differences were found in the average duration of gastroenteritis (4.7 +/- 2.2 days in the OR group, 4.0 +/- 2.1 days in the OR + R group; P = .15). The incidence of adverse events was similar in both groups (19 patients [20.2%] in the OR group, 18 patients [19.1%] in the OR + R group).
Conclusions:
In our study group, the use of racecadotril did not improve the symptoms of diarrhea compared with standard rehydration therapy.
Related Concept Videos
01:28Acute Pyelonephritis II: Diagnostic Studies and Management
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
01:16Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
01:18Bacterial Gastroenteritis
01:15Bioavailability Study Design: Healthy Subjects Versus Patients
01:17Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...